speb/financial-data huggingface dataset:
Financial ratios for HMR — annual report dated 2025-12-31
Total revenue: 65708068.23529412
Gross profit: 16849643.529411767
Operating income: -5808691.764705882
Net income: -26542508.23529412
Capital expenditures: 2971682.3529411764
Operating cash flow: 15536023.529411765
Depreciation & amortization: 89961.17647058824
Net tangible assets: 11734002.352941176
Owner earnings: -29424229.411764707
Return on net tangible assets (%): -250.7603844513411
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 58991997
Book value: 12598807.058823526
P/B ratio: 3.6522313140571865
Market cap (USD): 46013757.660000004
Debt to equity: 3.8188867741539685
Current ratio: 0.9368431932799158
Quick ratio: 0.936759368089447
COGS to revenue (%): 74.35681190767191
SG&A to revenue (%): 34.48333804759011
Free cash flow (dilution-adjusted): 6725730.588235294
Buyback yield (%): 0
Retained earnings: -21073569.411764707
Inventory turnover: 16950.882040816326
Receivables turnover: 7.55731263054874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.506584327604397
FCF margin (%): 10.235775862640057
Revenue growth (%): 117.8929956130804
Rule of 40 score: 128.12877147572047
Financial ratios for HMR — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 58991997
Market cap (USD): 46013757.660000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.76
Shares outstanding: 147292859
Market cap (USD): 701114008.8399999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFRX — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -34295603.19148936
Net income: -31366607.446808513
Capital expenditures: 172756.3829787234
Operating cash flow: -35896613.82978724
Depreciation & amortization: 634677.6595744682
Net tangible assets: 93840994.68085107
Owner earnings: -30904686.170212768
Return on net tangible assets (%): -32.933033452296826
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 147292859
Book value: 93988765.95744681
P/B ratio: 4.8581110545352635
Market cap (USD): 456607862.90000004
Debt to equity: 0.015355875487156454
Current ratio: 7.4781812364099105
Quick ratio: 7.4781812364099105
Interest coverage ratio: -712.4390497237569
Free cash flow (dilution-adjusted): -42499536.17021277
Buyback yield (%): 0
Retained earnings: -259000308.51063833
Receivables turnover: 0
Capitalized R&D asset: 39921372.340425536
ROCI (R&D-adjusted, %): -5.689905389910228
Rule of 40 score: 0
Financial ratios for IFRX — annual report dated 2023-12-31
Total revenue: 70098.88888888889
Gross profit: -521303.3333333333
Operating income: -49549840
Net income: -47408365.55555555
Capital expenditures: 90111.11111111111
Operating cash flow: -42014406.666666664
Depreciation & amortization: 630866.6666666666
Net tangible assets: 113903236.66666666
Owner earnings: -46867610
Return on net tangible assets (%): -41.14686410286673
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 147292859
Book value: 113979699.99999999
P/B ratio: 2.1064045630055177
Market cap (USD): 240087360.17
Debt to equity: 0.010918562204010404
Current ratio: 6.498872017168136
Quick ratio: 5.823993536539638
Interest coverage ratio: -1251.6800269450994
COGS to revenue (%): 843.6684683542298
R&D to revenue (%): 65025.80640048186
SG&A to revenue (%): 25554.6133240343
Free cash flow (dilution-adjusted): -45898394.44444444
Buyback yield (%): 0
Retained earnings: -317919798.8888889
Inventory turnover: 0.04682187162396406
Receivables turnover: 0.01663930768411136
Capitalized R&D asset: 72329687.24586289
ROCI (R&D-adjusted, %): -17.34635306274673
Rosenberg metric: -0.013058251827817214
FCF margin (%): -65476.63618063371
Rule of 40 score: -65476.63618063371
Financial ratios for IFRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.53
Shares outstanding: 147292859
Market cap (USD): 225358074.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFRX — annual report dated 2024-12-31
Total revenue: 172696.875
Gross profit: -3282552.0833333335
Operating income: -55109978.125
Net income: -47983752.083333336
Capital expenditures: 48823.958333333336
Operating cash flow: -50579885.41666667
Depreciation & amortization: 505327.0833333334
Net tangible assets: 63922144.79166667
Owner earnings: -47527248.958333336
Return on net tangible assets (%): -74.35177451137295
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 147292859
Book value: 63975040.62500001
P/B ratio: 5.686801574109981
Market cap (USD): 363813361.73
Debt to equity: 0.01310872555620202
Current ratio: 5.058174669421998
Quick ratio: 4.571274011354271
Interest coverage ratio: -2561.393318809005
COGS to revenue (%): 2000.7593989951083
R&D to revenue (%): 21330.665484441066
SG&A to revenue (%): 11656.70762233924
Free cash flow (dilution-adjusted): -54863925
Buyback yield (%): 0
Retained earnings: -346033563.5416667
Inventory turnover: 0.48089295712491736
Receivables turnover: 0.09553717293779011
Capitalized R&D asset: 80551631.99178487
ROCI (R&D-adjusted, %): -40.73158046383896
Rosenberg metric: -0.060577124107759894
FCF margin (%): -31768.915911188316
Revenue growth (%): 146.3617865237997
Rule of 40 score: -31622.554124664515
Financial ratios for IFRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 147292859
Market cap (USD): 363813361.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IFRX — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -10098.91304347826
Operating income: -14136019.56521739
Net income: -9036983.695652174
Capital expenditures: 11354.347826086956
Operating cash flow: -15234426.086956521
Depreciation & amortization: 123696.73913043478
Net tangible assets: 76534317.39130434
Owner earnings: -8924641.304347826
Return on net tangible assets (%): -11.660966751317526
Buffett classification: The Gruesome
Stock price: 1.02
Shares outstanding: 147292859
Book value: 76593159.78260869
P/B ratio: 1.961516101521553
Market cap (USD): 150238716.18
Debt to equity: 0.009971204858556234
Current ratio: 5.283989674162107
Quick ratio: 4.85840400072213
Interest coverage ratio: -3182.8531571218796
Free cash flow (dilution-adjusted): -17941439.13043478
Buyback yield (%): 0
Retained earnings: -370115486.95652175
Inventory turnover: 0.0013474256860145741
Receivables turnover: 0
Capitalized R&D asset: 7626452.173913043
ROCI (R&D-adjusted, %): -10.701855336974376
Rule of 40 score: 0
Financial ratios for IFRX — quarterly report dated 2025-06-30
Total revenue: 46390.58823529412
Gross profit: -2776648.2352941176
Operating income: -15088417.647058824
Net income: -16851103.529411767
Capital expenditures: 17914.117647058825
Operating cash flow: -8885994.11764706
Depreciation & amortization: 135294.11764705883
Net tangible assets: 67052070.5882353
Owner earnings: -16733723.529411767
Return on net tangible assets (%): -24.95631138995401
Buffett classification: The Gruesome
Stock price: 0.79
Shares outstanding: 147292859
Book value: 67111017.64705881
P/B ratio: 1.7338637185022572
Market cap (USD): 116361358.61
Debt to equity: 0.010502562347744602
Current ratio: 4.0955916898954285
Quick ratio: 3.783751715117851
Interest coverage ratio: -3822.698956780924
COGS to revenue (%): 6085.3697504564825
R&D to revenue (%): 18266.742747007505
SG&A to revenue (%): 10651.247717589775
Free cash flow (dilution-adjusted): -10208035.294117648
Buyback yield (%): 0
Retained earnings: -417555904.7058824
Inventory turnover: 0.47625751352359824
Receivables turnover: 0.022485826607315764
Capitalized R&D asset: 13583772.368286446
ROCI (R&D-adjusted, %): -14.795620608350529
Rosenberg metric: -0.36275705389117463
FCF margin (%): -22004.539460336782
Rule of 40 score: -22004.539460336782
Financial ratios for IFRX — quarterly report dated 2025-09-30
Total revenue: 28035.29411764706
Gross profit: 27643.529411764706
Operating income: -11149417.647058824
Net income: -14424810.588235294
Capital expenditures: 103496.4705882353
Operating cash flow: -10635248.235294119
Depreciation & amortization: 117403.52941176471
Net tangible assets: 53318394.11764706
Owner earnings: -14410903.529411765
Return on net tangible assets (%): -27.02801494286212
Buffett classification: The Gruesome
Stock price: 1.34
Shares outstanding: 147292859
Book value: 53372723.52941176
P/B ratio: 3.698001863278258
Market cap (USD): 197372431.06
Debt to equity: 0.02140026801528827
Current ratio: 3.3310398445112726
Quick ratio: 3.064872414701268
Interest coverage ratio: -660.0045267776309
COGS to revenue (%): 1.3973982375157366
R&D to revenue (%): 26188.94250944188
SG&A to revenue (%): 15897.494754511117
Free cash flow (dilution-adjusted): -11439778.823529413
Buyback yield (%): 0
Retained earnings: -431980715.2941176
Inventory turnover: 6.566305388412738e-05
Receivables turnover: 0.012122303512364953
Capitalized R&D asset: 15536489.382097188
ROCI (R&D-adjusted, %): -16.65535059303257
Rosenberg metric: 0.33092700177233136
FCF margin (%): -40804.91817037348
Revenue growth (%): -39.566849259484684
Rule of 40 score: -40844.485019632964
Financial ratios for IFRX — quarterly report dated 2025-12-31
Total revenue: -39918.82352941176
Gross profit: -5755696.470588235
Operating income: -15125695.294117648
Net income: -12520461.176470589
Capital expenditures: 2410.5882352941176
Operating cash flow: -5536000
Depreciation & amortization: 106928.23529411765
Net tangible assets: 48840618.823529415
Owner earnings: -12415943.529411765
Return on net tangible assets (%): -25.42134769887533
Buffett classification: The Gruesome
Stock price: 1.01
Shares outstanding: 147292859
Book value: 48890330.5882353
P/B ratio: 3.042846832903155
Market cap (USD): 148765787.59
Debt to equity: 0.021606967103635865
Current ratio: 4.131556535193557
Quick ratio: 4.131556535193557
Interest coverage ratio: -737.2464590859569
Free cash flow (dilution-adjusted): -5844582.352941177
Buyback yield (%): 0
Retained earnings: -444501177.64705884
Receivables turnover: -0.023754084910124974
Capitalized R&D asset: 13904714.835294118
ROCI (R&D-adjusted, %): -25.587498558221476
Rosenberg metric: -0.7876905697564024
Revenue growth (%): -242.38774653797734
Rule of 40 score: -242.38774653797734
Financial ratios for IFRX — annual report dated 2025-12-31
Total revenue: 34507.05882352941
Gross profit: -8515631.764705883
Operating income: -56772910.5882353
Net income: -53686800
Capital expenditures: 136110.58823529413
Operating cash flow: -41546268.23529412
Depreciation & amortization: 493509.4117647059
Net tangible assets: 48840618.823529415
Owner earnings: -53329401.17647059
Return on net tangible assets (%): -109.19067460868999
Buffett classification: The Gruesome
Stock price: 1.01
Shares outstanding: 147292859
Book value: 48890330.5882353
P/B ratio: 3.042846832903155
Market cap (USD): 148765787.59
Debt to equity: 0.021606967103635865
Current ratio: 4.131556535193557
Quick ratio: 4.131556535193557
Interest coverage ratio: -1229.8217079945973
COGS to revenue (%): 24777.941427158978
R&D to revenue (%): 87691.48000409124
SG&A to revenue (%): 59884.69878285773
Free cash flow (dilution-adjusted): -46911365.88235295
Buyback yield (%): 0
Retained earnings: -444501177.64705884
Receivables turnover: 0.0205337615896636
Capitalized R&D asset: 69982985.0694853
ROCI (R&D-adjusted, %): -53.54105127469854
Rosenberg metric: -0.14205890527612516
FCF margin (%): -135947.1582966827
Revenue growth (%): -80.01871265850676
Rule of 40 score: -136027.1770093412
Financial ratios for IMMP — annual report dated 2021-06-30
Total revenue: 0
Operating income: -14779006.766917292
Net income: -22483175.939849623
Capital expenditures: 11730.075187969924
Net tangible assets: 45431851.879699245
Owner earnings: -22494906.015037593
Return on net tangible assets (%): -49.51351328271347
Buffett classification: The Gruesome
Stock price: 3.87
Shares outstanding: 147372131
Book value: 55091436.84210526
P/B ratio: 10.352428247689273
Market cap (USD): 570330146.97
Debt to equity: 0.03842111510281929
Current ratio: 12.812480875675881
Quick ratio: 12.812480875675881
Interest coverage ratio: -2000.618727735369
Free cash flow (dilution-adjusted): -13275145.112781955
Buyback yield (%): 0
Retained earnings: -206497909.7744361
Receivables turnover: 0
Capitalized R&D asset: 12959984.962406015
ROCI (R&D-adjusted, %): -8.692782870460054
Rule of 40 score: 0
Financial ratios for IMMP — annual report dated 2022-06-30
Total revenue: 117495.86206896552
Operating income: -23336095.172413792
Net income: -22214362.75862069
Capital expenditures: 15802.758620689656
Operating cash flow: -30306473.027586207
Depreciation & amortization: 2068698.924137931
Net tangible assets: 57602273.10344828
Owner earnings: -20161466.59310345
Return on net tangible assets (%): -35.001164896557725
Buffett classification: The Gruesome
Stock price: 2.03
Shares outstanding: 147372131
Book value: 64880942.068965524
P/B ratio: 4.610990783888442
Market cap (USD): 299165425.92999995
Debt to equity: 0.018429714539414294
Current ratio: 14.157281405068836
Quick ratio: 14.157281405068836
Interest coverage ratio: -366.0860975873634
COGS to revenue (%): 0
R&D to revenue (%): 18396.29040494456
SG&A to revenue (%): 4232.062757896097
Free cash flow (dilution-adjusted): -22354522.08275862
Buyback yield (%): 0
Retained earnings: -208507040.68965518
Receivables turnover: 0.02034584679321443
Capitalized R&D asset: 30298069.92481203
ROCI (R&D-adjusted, %): -13.749962982000428
FCF margin (%): -19025.79519748311
Rule of 40 score: -19025.79519748311
Financial ratios for IMMP — annual report dated 2023-06-30
Total revenue: 0
Operating income: -27437950.33112583
Net income: -26421422.516556293
Capital expenditures: 54791.39072847682
Net tangible assets: 84092163.57615894
Owner earnings: -26476213.90728477
Return on net tangible assets (%): -31.484757653198344
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 147372131
Book value: 90377078.80794702
P/B ratio: 3.4406422569906865
Market cap (USD): 310955196.40999997
Debt to equity: 0.00900031874547339
Current ratio: 13.811285305337458
Quick ratio: 13.811285305337458
Interest coverage ratio: -2030.8467722170483
Free cash flow (dilution-adjusted): -23469241.721854303
Buyback yield (%): 0
Retained earnings: -225119557.61589405
Receivables turnover: 0
Capitalized R&D asset: 42770146.75679928
ROCI (R&D-adjusted, %): -17.13762599928234
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for IMMP — annual report dated 2024-06-30
Total revenue: 0
Operating income: -31038308
Net income: -28477750
Capital expenditures: 19476.666666666668
Net tangible assets: 120853870
Owner earnings: -28497226.666666668
Return on net tangible assets (%): -23.579904116158357
Buffett classification: The Gruesome
Stock price: 2.01
Shares outstanding: 147372131
Book value: 126347828.00000001
P/B ratio: 2.3444643884974417
Market cap (USD): 296217983.30999994
Debt to equity: 0.008409541740071172
Current ratio: 18.24756998429959
Quick ratio: 18.24756998429959
Interest coverage ratio: -1521.784075308884
Free cash flow (dilution-adjusted): -23835732
Buyback yield (%): 0
Retained earnings: -255098104.66666666
Receivables turnover: 0
Capitalized R&D asset: 50918352.419867545
ROCI (R&D-adjusted, %): -15.58032891889721
Rule of 40 score: 0
Financial ratios for IMMP — quarterly report dated 2024-09-30
Capital expenditures: 689.6551724137931
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 147372131
Market cap (USD): 325692409.51
Free cash flow (dilution-adjusted): -5926896.551724138
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMMP — quarterly report dated 2024-12-31
Capital expenditures: 6522.360248447205
Net tangible assets: 102295301.86335403
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 147372131
Book value: 107125593.78881988
P/B ratio: 2.985257891782865
Market cap (USD): 319797524.27
Debt to equity: 0.009768629039278363
Current ratio: 18.86280862349765
Quick ratio: 18.86280862349765
Free cash flow (dilution-adjusted): -12539862.732919253
Buyback yield (%): 0
Retained earnings: -251568065.8385093
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMMP — quarterly report dated 2025-03-31
Capital expenditures: 20340880.50314465
Buffett classification: The Gruesome
Stock price: 1.76
Shares outstanding: 147372131
Market cap (USD): 259374950.56
Free cash flow (dilution-adjusted): -10227672.955974841
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMMP — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 147372131
Market cap (USD): 241690294.83999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMMP — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 147372131
Market cap (USD): 241690294.83999997
Buyback yield (%): 0
Capitalized R&D asset: 26481292.81933775
Rule of 40 score: 0
Financial ratios for IMMP — quarterly report dated 2025-12-31
Capital expenditures: 58830.20134228188
Net tangible assets: 62378481.87919463
Buffett classification: The Gruesome
Stock price: 2.86
Shares outstanding: 147372131
Book value: 66375025.503355704
P/B ratio: 6.350043430698058
Market cap (USD): 421484294.65999997
Debt to equity: 0.012230746447570218
Current ratio: 2.973428777977211
Quick ratio: 2.973428777977211
Free cash flow (dilution-adjusted): -6510203.355704698
Buyback yield (%): 0
Retained earnings: -326410440.9395973
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX — annual report dated 2022-06-30
Total revenue: 0
Operating income: -21870007
Net income: -21521237
Capital expenditures: 2816467
Operating cash flow: -12134077
Depreciation & amortization: 153434
Net tangible assets: 7419719
Owner earnings: -24184270
Return on net tangible assets (%): -325.9459017248497
Buffett classification: The Gruesome
Stock price: 5.8
Shares outstanding: 36213407
Book value: 7419719
P/B ratio: 28.30804786542455
Market cap (USD): 210037760.6
Debt to equity: 0.07318740777110293
Current ratio: 2.8073608152358647
Quick ratio: 2.8073608152358647
Interest coverage ratio: -480.2267626973496
Free cash flow (dilution-adjusted): -23290872
Buyback yield (%): 0
Retained earnings: -34752074
Receivables turnover: 0
Capitalized R&D asset: 1239909
ROCI (R&D-adjusted, %): -234.11599893299942
Rule of 40 score: 0
Financial ratios for IPX — annual report dated 2023-06-30
Total revenue: 0
Operating income: -17661555
Net income: -17444754
Capital expenditures: 2705586
Operating cash flow: -15864394
Depreciation & amortization: 426534
Net tangible assets: 20563228
Owner earnings: -19723806
Return on net tangible assets (%): -95.91784908478377
Buffett classification: The Gruesome
Stock price: 7.29
Shares outstanding: 36213407
Book value: 20563228
P/B ratio: 12.83824392892011
Market cap (USD): 263995737.03
Debt to equity: 0.0474300046665825
Current ratio: 7.741310946280663
Quick ratio: 7.741310946280663
Interest coverage ratio: -200.38524813360866
Free cash flow (dilution-adjusted): -21159393
Buyback yield (%): 0
Retained earnings: -52196828
Receivables turnover: 0
Capitalized R&D asset: 6402856.03
ROCI (R&D-adjusted, %): -52.13399681848354
Rule of 40 score: 0
Financial ratios for IPX — annual report dated 2024-06-30
Total revenue: 0
Operating income: -22617268
Net income: -21843646
Capital expenditures: 6029569
Operating cash flow: -18607063
Depreciation & amortization: 645851
Net tangible assets: 51339595
Owner earnings: -27227364
Return on net tangible assets (%): -53.033850383899605
Buffett classification: The Gruesome
Stock price: 13.93
Shares outstanding: 36213407
Book value: 51339595
P/B ratio: 9.825803252051365
Market cap (USD): 504452759.51
Debt to equity: 0.02903554264500918
Current ratio: 13.616136759060897
Quick ratio: 13.610591728794274
Interest coverage ratio: -184.2757463172989
Free cash flow (dilution-adjusted): -30468256
Buyback yield (%): 0
Retained earnings: -73882050
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 12821153.48
ROCI (R&D-adjusted, %): -29.19293628032351
Rule of 40 score: 0
Financial ratios for IPX — quarterly report dated 2024-09-30
Capital expenditures: 2830000
Buffett classification: The Gruesome
Stock price: 22.27
Shares outstanding: 36213407
Market cap (USD): 806472573.89
Free cash flow (dilution-adjusted): -6342000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX — quarterly report dated 2024-12-31
Capital expenditures: 1653858
Net tangible assets: 91393947
Buffett classification: The Gruesome
Stock price: 34.4
Shares outstanding: 36213407
Book value: 105542403
P/B ratio: 11.803229464085632
Market cap (USD): 1245741200.8
Debt to equity: 0.03970952793257891
Current ratio: 11.803532003537876
Quick ratio: 11.803532003537876
Free cash flow (dilution-adjusted): -16390664
Buyback yield (%): 0
Retained earnings: -90118921
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX — quarterly report dated 2025-03-31
Capital expenditures: 4562000
Buffett classification: The Gruesome
Stock price: 17.99
Shares outstanding: 36213407
Market cap (USD): 651479191.93
Free cash flow (dilution-adjusted): -11079000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.5
Shares outstanding: 36213407
Market cap (USD): 1140722320.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPX — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.5
Shares outstanding: 36213407
Market cap (USD): 1140722320.5
Buyback yield (%): 0
Capitalized R&D asset: 7685664.19
Rule of 40 score: 0
Financial ratios for IPX — quarterly report dated 2025-12-31
Capital expenditures: 5450599
Net tangible assets: 95290241
Buffett classification: The Gruesome
Stock price: 36.19
Shares outstanding: 36213407
Book value: 108201890
P/B ratio: 12.112202470123211
Market cap (USD): 1310563199.33
Debt to equity: 0.041207653581651855
Current ratio: 4.0287632684603185
Quick ratio: 4.004111271933621
Free cash flow (dilution-adjusted): -15223064
Buyback yield (%): 0
Retained earnings: -143998841
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IZM — annual report dated 2023-06-30
Total revenue: 29573134.620689657
Gross profit: 730015.3103448276
Operating income: 139036.6896551724
Net income: 314828.9655172414
Capital expenditures: 11298.344827586207
Operating cash flow: -517494.0689655172
Depreciation & amortization: 79865.93103448275
Net tangible assets: 2104242.7586206896
Owner earnings: 383396.551724138
Return on net tangible assets (%): 18.22016733351862
Capex to operating income (%): 8.126160695861971
Buffett classification: The Great
Stock price: 4.72
P/E ratio: 122.76582981016513
Shares outstanding: 8188610
Book value: 2144027.0344827585
P/B ratio: 18.026936497712715
Market cap (USD): 38650239.199999996
Debt to equity: 0.9599902754700211
Current ratio: 1.2024871061580464
Quick ratio: 1.1909468709191438
Effective tax rate (%): -13.172586818984156
Interest coverage ratio: 1.7749416726094576
COGS to revenue (%): 97.53149160645926
R&D to revenue (%): 0.20394139086889607
SG&A to revenue (%): 2.0444762852935305
Free cash flow (dilution-adjusted): -720421.9310344828
Buyback yield (%): 0
Retained earnings: -735765.5172413794
Inventory turnover: 250.77724864425355
Receivables turnover: 2.749589873527848
Capitalized R&D asset: 125487.7326572008
ROCI (R&D-adjusted, %): 6.056442207542833
Rosenberg metric: -5.514278046511241
FCF margin (%): -2.436068885746283
Revenue growth (%): -31.76441964741659
Rule of 40 score: -34.200488533162876
Financial ratios for IZM — annual report dated 2024-06-30
Total revenue: 24475088.033012383
Gross profit: 680929.9862448418
Operating income: -161919.3947730399
Net income: -312558.04676753783
Capital expenditures: 13096.14855570839
Operating cash flow: 286416.7812929849
Depreciation & amortization: 117468.63823933977
Net tangible assets: 2087576.478679505
Owner earnings: -208185.55708390646
Return on net tangible assets (%): -9.972595457465303
Buffett classification: The Gruesome
Stock price: 1.9
Shares outstanding: 8188610
Book value: 2115641.540577716
P/B ratio: 7.353967438052616
Market cap (USD): 15558359
Debt to equity: 0.7907779833888078
Current ratio: 1.5911012896957377
Quick ratio: 1.5773059951058632
Interest coverage ratio: -1.68910960987677
COGS to revenue (%): 97.21786501717014
R&D to revenue (%): 0.27063309861881846
SG&A to revenue (%): 3.462576465899778
Free cash flow (dilution-adjusted): 104972.21458046767
Buyback yield (%): 0
Retained earnings: -1046299.4497936727
Inventory turnover: 509.84576139304306
Receivables turnover: 6.186365281985597
Capitalized R&D asset: 132758.20686888567
ROCI (R&D-adjusted, %): -7.304760327577392
Rosenberg metric: -0.8138585415230191
FCF margin (%): 0.42889412466618915
Revenue growth (%): -17.238776521548143
Rule of 40 score: -16.809882396881953
Financial ratios for LDOS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84
Shares outstanding: 125785466
Market cap (USD): 10565979144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LDOS — annual report dated 2022-12-31
Total revenue: 14396000000
Gross profit: 2084000000
Operating income: 1133000000
Net income: 693000000
Capital expenditures: 129000000
Operating cash flow: 992000000
Depreciation & amortization: 333000000
Net tangible assets: -3349000000
Owner earnings: 897000000
Return on net tangible assets (%): -26.78411466109286
Capex to operating income (%): 11.385701676963812
Buffett classification: The Great
Stock price: 100.83
P/E ratio: 18.30151304008658
Shares outstanding: 125785466
Book value: 4353000000
P/B ratio: 2.913610966409373
Market cap (USD): 12682948536.78
Debt to equity: 1.261199172984149
Current ratio: 0.9229794780846212
Quick ratio: 0.8502660248289841
Effective tax rate (%): 21.783295711060948
Interest coverage ratio: 5.693467336683417
COGS to revenue (%): 85.52375659905529
SG&A to revenue (%): 6.606001667129759
Free cash flow (dilution-adjusted): 790000000
Buyback yield (%): 4.273454224214689
Retained earnings: 2367000000
Inventory turnover: 42.89895470383275
Receivables turnover: 6.125957446808511
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.417799210872424
FCF margin (%): 5.487635454292859
Rule of 40 score: 5.487635454292859
Financial ratios for LDOS — annual report dated 2023-12-31
Total revenue: 15438000000
Gross profit: 2244000000
Operating income: 1302000000
Net income: 208000000
Capital expenditures: 207000000
Operating cash flow: 1187000000
Depreciation & amortization: 331000000
Net tangible assets: -2578000000
Owner earnings: 332000000
Return on net tangible assets (%): -12.878200155159039
Capex to operating income (%): 15.898617511520738
Buffett classification: The Great
Stock price: 105.37
P/E ratio: 63.721223809711546
Shares outstanding: 125785466
Book value: 4258000000
P/B ratio: 3.1127323984077035
Market cap (USD): 13254014552.42
Debt to equity: 1.2207609206200094
Current ratio: 1.339464882943144
Quick ratio: 1.2357859531772575
Effective tax rate (%): 48.38709677419355
Interest coverage ratio: 6.1415094339622645
COGS to revenue (%): 85.46443839875631
SG&A to revenue (%): 6.101826661484648
Free cash flow (dilution-adjusted): 903000000
Buyback yield (%): 1.8560414207111595
Retained earnings: 2364000000
Inventory turnover: 42.561290322580646
Receivables turnover: 6.355701934952656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.415765069551778
FCF margin (%): 5.84920326467159
Revenue growth (%): 7.2381217004723535
Rule of 40 score: 13.087324965143942
Financial ratios for LDOS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 159.97
Shares outstanding: 125785466
Market cap (USD): 20121900996.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LDOS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 141.75
Shares outstanding: 125785466
Market cap (USD): 17830089805.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LDOS — annual report dated 2024-12-31
Total revenue: 16662000000
Gross profit: 2798000000
Operating income: 1815000000
Net income: 1254000000
Capital expenditures: 149000000
Operating cash flow: 1435000000
Depreciation & amortization: 290000000
Net tangible assets: -2189000000
Owner earnings: 1395000000
Return on net tangible assets (%): -63.72772955687529
Capex to operating income (%): 8.209366391184574
Buffett classification: The Great
Stock price: 141.75
P/E ratio: 14.218572412679425
Shares outstanding: 125785466
Book value: 4460000000
P/B ratio: 3.997777983295964
Market cap (USD): 17830089805.5
Debt to equity: 1.186322869955157
Current ratio: 1.2174157303370787
Quick ratio: 1.128932584269663
Effective tax rate (%): 23.672971323978036
Interest coverage ratio: 9.404145077720207
COGS to revenue (%): 83.20729804345217
SG&A to revenue (%): 5.899651902532709
Free cash flow (dilution-adjusted): 1201000000
Buyback yield (%): 5.081298018591744
Retained earnings: 3410000000
Inventory turnover: 44.01269841269841
Receivables turnover: 6.299432892249527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.20634920634921
FCF margin (%): 7.20801824510863
Revenue growth (%): 7.928488146132919
Rule of 40 score: 15.13650639124155
Financial ratios for LDOS — quarterly report dated 2025-03-31
Total revenue: 4245000000
Gross profit: 757000000
Operating income: 527000000
Net income: 365000000
Capital expenditures: 22000000
Operating cash flow: 58000000
Depreciation & amortization: 69000000
Net tangible assets: -2330000000
Owner earnings: 412000000
Return on net tangible assets (%): -17.682403433476395
Capex to operating income (%): 4.174573055028463
Buffett classification: The Great
Stock price: 133.18
P/E ratio: 11.47404682320548
Shares outstanding: 125785466
Book value: 4302000000
P/B ratio: 3.894027978121804
Market cap (USD): 16752108361.880001
Debt to equity: 1.3333333333333333
Current ratio: 1.536305302262749
Quick ratio: 1.4191151637960149
Effective tax rate (%): 23.640167364016737
Interest coverage ratio: 10.755102040816327
COGS to revenue (%): 82.16725559481743
SG&A to revenue (%): 5.418138987043581
Free cash flow (dilution-adjusted): 15000000
Buyback yield (%): 3.1518420761978962
Retained earnings: 3721000000
Inventory turnover: 10.051873198847263
Receivables turnover: 1.4607708189951825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.148495506057054
FCF margin (%): 0.35335689045936397
Rule of 40 score: 0.35335689045936397
Financial ratios for LDOS — quarterly report dated 2025-06-30
Total revenue: 4253000000
Gross profit: 782000000
Operating income: 565000000
Net income: 393000000
Capital expenditures: 29000000
Operating cash flow: 486000000
Depreciation & amortization: 72000000
Net tangible assets: -2212000000
Owner earnings: 436000000
Return on net tangible assets (%): -19.710669077757686
Capex to operating income (%): 5.132743362831858
Buffett classification: The Great
Stock price: 156.12
P/E ratio: 25.90715956717678
Shares outstanding: 125785466
Book value: 4707000000
P/B ratio: 4.17200487612492
Market cap (USD): 19637626951.920002
Debt to equity: 1.2113872955173146
Current ratio: 1.6217774762550883
Quick ratio: 1.4983039348710991
Effective tax rate (%): 24.13127413127413
Interest coverage ratio: 10.272727272727273
COGS to revenue (%): 81.6129790735951
SG&A to revenue (%): 5.102280743004937
Free cash flow (dilution-adjusted): 432000000
Buyback yield (%): 0.04583038481194926
Retained earnings: 4061000000
Inventory turnover: 9.535714285714286
Receivables turnover: 1.4590051457975985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.3296858786906895
FCF margin (%): 10.157535857042088
Revenue growth (%): 0.18845700824499412
Rule of 40 score: 10.345992865287082
Financial ratios for LDOS — quarterly report dated 2025-09-30
Total revenue: 4469000000
Gross profit: 821000000
Operating income: 535000000
Net income: 369000000
Capital expenditures: 31000000
Operating cash flow: 711000000
Depreciation & amortization: 74000000
Net tangible assets: -1929000000
Owner earnings: 412000000
Return on net tangible assets (%): -21.358216692586833
Capex to operating income (%): 5.794392523364486
Buffett classification: The Great
Stock price: 187.4
P/E ratio: 20.915879617036378
Shares outstanding: 125785466
Book value: 4954000000
P/B ratio: 4.758214842228502
Market cap (USD): 23572196328.4
Debt to equity: 1.0555106984255147
Current ratio: 1.6239115874079035
Quick ratio: 1.5033489618218352
Effective tax rate (%): 23.7603305785124
Interest coverage ratio: 10.490196078431373
COGS to revenue (%): 81.6289997762363
SG&A to revenue (%): 6.399641978071156
Free cash flow (dilution-adjusted): 654000000
Buyback yield (%): 0.43271317860656644
Retained earnings: 4375000000
Inventory turnover: 10.133333333333333
Receivables turnover: 1.5047138047138047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.068207654414551
FCF margin (%): 14.634146341463413
Revenue growth (%): 5.078767928521044
Rule of 40 score: 19.71291426998446
Financial ratios for LDOS — quarterly report dated 2025-12-31
Total revenue: 4207000000
Gross profit: 739000000
Operating income: 473000000
Net income: 335000000
Capital expenditures: 43000000
Operating cash flow: 495000000
Depreciation & amortization: 75000000
Net tangible assets: -1884000000
Owner earnings: 367000000
Return on net tangible assets (%): -19.47983014861996
Capex to operating income (%): 9.090909090909092
Buffett classification: The Great
Stock price: 179.32
P/E ratio: 15.428077813351573
Shares outstanding: 125785466
Book value: 4962000000
P/B ratio: 4.545717404901249
Market cap (USD): 22555849763.12
Debt to equity: 1.055018137847642
Current ratio: 1.7028652281570569
Quick ratio: 1.5818889281924302
Effective tax rate (%): 21.91142191142191
Interest coverage ratio: 9.854166666666666
COGS to revenue (%): 82.43403850724982
SG&A to revenue (%): 6.322795341098169
Free cash flow (dilution-adjusted): 429000000
Buyback yield (%): 1.3521991111090437
Retained earnings: 4647000000
Inventory turnover: 10.140350877192983
Receivables turnover: 1.5535450516986706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.43465216576036
FCF margin (%): 10.1972902305681
Revenue growth (%): -5.8626090848064445
Rule of 40 score: 4.334681145761656
Financial ratios for LDOS — annual report dated 2025-12-31
Total revenue: 17174000000
Gross profit: 3099000000
Operating income: 2100000000
Net income: 1462000000
Capital expenditures: 125000000
Operating cash flow: 1750000000
Depreciation & amortization: 290000000
Net tangible assets: -1884000000
Owner earnings: 1627000000
Return on net tangible assets (%): -86.3588110403397
Capex to operating income (%): 5.952380952380952
Buffett classification: The Great
Stock price: 179.32
P/E ratio: 15.428077813351573
Shares outstanding: 125785466
Book value: 4962000000
P/B ratio: 4.545717404901249
Market cap (USD): 22555849763.12
Debt to equity: 1.055018137847642
Current ratio: 1.7028652281570569
Quick ratio: 1.5818889281924302
Effective tax rate (%): 23.415400733368255
Interest coverage ratio: 10.344827586206897
COGS to revenue (%): 81.95528123908234
SG&A to revenue (%): 5.816932572493304
Free cash flow (dilution-adjusted): 1530000000
Buyback yield (%): 4.1851670848752045
Retained earnings: 4647000000
Inventory turnover: 41.154970760233915
Receivables turnover: 6.341949778434269
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.6887305456591
FCF margin (%): 8.908815651566321
Revenue growth (%): 3.0728604009122553
Rule of 40 score: 11.981676052478576
Financial ratios for LOGN.SW — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 70.21739130434781
Shares outstanding: 143566251
Market cap (USD): 10080847624.565216
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOGN.SW — annual report dated 2023-03-31
Total revenue: 4987712087.912087
Gross profit: 1889576923.076923
Operating income: 541804395.6043956
Net income: 400631868.1318681
Capital expenditures: 101486813.18681319
Operating cash flow: 586824175.8241758
Depreciation & amortization: 110676923.07692307
Net tangible assets: 1911842857.142857
Owner earnings: 409821978.021978
Return on net tangible assets (%): 21.435965643872752
Capex to operating income (%): 18.73126427363186
Buffett classification: The Great
Stock price: 55.670329670329664
P/E ratio: 19.949437771816495
Shares outstanding: 143566251
Book value: 2480835164.835165
P/B ratio: 3.221649159118694
Market cap (USD): 7992380522.703296
Debt to equity: 0.031456971243289215
Current ratio: 2.4808652832520877
Quick ratio: 1.8305572670213606
Effective tax rate (%): 21.346775341839223
COGS to revenue (%): 62.11535690569659
R&D to revenue (%): 6.186544602581553
SG&A to revenue (%): 20.574387428621286
Free cash flow (dilution-adjusted): 407554945.054945
Buyback yield (%): 5.751989383075393
Retained earnings: 3491840659.340659
Inventory turnover: 4.128469613834085
Receivables turnover: 6.5710926924608195
Capitalized R&D asset: 308567032.96703297
ROCI (R&D-adjusted, %): 24.368743227813198
FCF margin (%): 8.171180250012227
Rule of 40 score: 8.171180250012227
Financial ratios for LOGN.SW — annual report dated 2024-03-31
Total revenue: 4776074444.444445
Gross profit: 1975578888.8888888
Operating income: 660531111.111111
Net income: 680158888.8888888
Capital expenditures: 62107777.777777776
Operating cash flow: 1272351111.1111112
Depreciation & amortization: 94162222.22222222
Net tangible assets: 1918968888.8888888
Owner earnings: 712213333.3333333
Return on net tangible assets (%): 37.114376239091364
Capex to operating income (%): 9.402702875463852
Buffett classification: The Great
Stock price: 86.0989010989011
P/E ratio: 18.17354245885375
Shares outstanding: 143566251
Book value: 2481836666.6666665
P/B ratio: 4.980543889937295
Market cap (USD): 12360896445.98901
Debt to equity: 0.03448476553878333
Current ratio: 2.4232126856428238
Quick ratio: 2.034118588548185
Effective tax rate (%): 1.52076268187054
COGS to revenue (%): 58.635927645832794
R&D to revenue (%): 6.682452139332465
SG&A to revenue (%): 20.59725013592055
Free cash flow (dilution-adjusted): 1118144444.4444444
Buyback yield (%): 4.532240505399131
Retained earnings: 4002798888.888889
Inventory turnover: 5.965369112903034
Receivables turnover: 7.3744430738719515
Capitalized R&D asset: 525898800.97680104
ROCI (R&D-adjusted, %): 23.174281606608513
Rosenberg metric: 0.27871404467616706
FCF margin (%): 23.411369681330573
Revenue growth (%): -4.243180835969959
Rule of 40 score: 19.168188845360614
Financial ratios for LOGN.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.66666666666667
Shares outstanding: 143566251
Market cap (USD): 12729540922
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOGN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.18888888888888
Shares outstanding: 143566251
Market cap (USD): 11799550651.633333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOGN.SW — quarterly report dated 2025-03-31
Total revenue: 1148130681.8181818
Gross profit: 495239772.72727275
Operating income: 130447727.27272727
Net income: 163711363.63636363
Capital expenditures: 14531818.181818182
Operating cash flow: 147336363.63636363
Depreciation & amortization: 23097727.272727273
Net tangible assets: 1863136363.6363637
Owner earnings: 172277272.72727272
Return on net tangible assets (%): 9.246627143867867
Capex to operating income (%): 11.139955049915502
Buffett classification: The Great
Stock price: 82.79545454545455
P/E ratio: 18.151814182145685
Shares outstanding: 143566251
Book value: 2417522727.272727
P/B ratio: 4.916865051498999
Market cap (USD): 11886633008.931818
Debt to equity: 0.04343383064933112
Current ratio: 2.35467705153716
Quick ratio: 1.8971781572606758
Effective tax rate (%): -21.876031030311232
COGS to revenue (%): 56.865557155653214
R&D to revenue (%): 7.870797887871095
SG&A to revenue (%): 23.64159132186212
Free cash flow (dilution-adjusted): 117070454.54545455
Buyback yield (%): 1.1999345657819354
Retained earnings: 4121887500
Inventory turnover: 1.1405407873396765
Receivables turnover: 2.0171678532496933
Capitalized R&D asset: 90367045.45454545
ROCI (R&D-adjusted, %): 6.66720170831913
FCF margin (%): 10.196614061394262
Rule of 40 score: 10.196614061394262
Financial ratios for LOGN.SW — annual report dated 2025-03-31
Total revenue: 5176022727.272727
Gross profit: 2230228409.090909
Operating income: 755079545.4545455
Net income: 717646590.9090909
Capital expenditures: 63781818.18181818
Operating cash flow: 957451136.3636364
Depreciation & amortization: 90638636.36363636
Net tangible assets: 1863136363.6363637
Owner earnings: 744503409.0909091
Return on net tangible assets (%): 39.95968430554539
Capex to operating income (%): 8.44703297364817
Buffett classification: The Great
Stock price: 82.79545454545455
P/E ratio: 16.563351877522646
Shares outstanding: 143566251
Book value: 2417522727.272727
P/B ratio: 4.916865051498999
Market cap (USD): 11886633008.931818
Debt to equity: 0.04343383064933112
Current ratio: 2.35467705153716
Quick ratio: 1.8971781572606758
Effective tax rate (%): 10.658648241831619
COGS to revenue (%): 56.91231421106939
R&D to revenue (%): 6.784078684493624
SG&A to revenue (%): 21.480778941359855
Free cash flow (dilution-adjusted): 791495454.5454545
Buyback yield (%): 5.629298813266062
Retained earnings: 4121887500
Inventory turnover: 5.146033624021582
Receivables turnover: 9.093831232355981
Capitalized R&D asset: 666809030.9801309
ROCI (R&D-adjusted, %): 22.69495468479322
Rosenberg metric: 0.7978769480259507
FCF margin (%): 15.291576104854112
Revenue growth (%): 8.373995997769764
Rule of 40 score: 23.665572102623877
Financial ratios for LOGN.SW — quarterly report dated 2025-06-30
Total revenue: 1434628750
Gross profit: 598702500
Operating income: 205170000
Net income: 182518750
Capital expenditures: 20345000
Operating cash flow: 156306250
Depreciation & amortization: 24823750
Net tangible assets: 2126422500
Owner earnings: 186997500
Return on net tangible assets (%): 8.793995548861997
Capex to operating income (%): 9.916167080957255
Buffett classification: The Great
Stock price: 88.02499999999999
P/E ratio: 36.50005804390472
Shares outstanding: 143566251
Book value: 2734065000
P/B ratio: 4.622208778604385
Market cap (USD): 12637419244.275
Debt to equity: 0.04280668162607692
Current ratio: 2.272157085327515
Quick ratio: 1.8634221623195422
Effective tax rate (%): 16.31658881852308
COGS to revenue (%): 58.267774851159224
R&D to revenue (%): 6.4988067470417
SG&A to revenue (%): 20.701610085536064
Free cash flow (dilution-adjusted): 94926250
Buyback yield (%): 1.2033410228824313
Retained earnings: 4699461250
Inventory turnover: 1.3380975248614362
Receivables turnover: 1.692580068104159
Capitalized R&D asset: 153779670.45454547
ROCI (R&D-adjusted, %): 7.179111832819407
Rosenberg metric: 1.144916565018925
FCF margin (%): 6.616781519260645
Revenue growth (%): 24.95343715822657
Rule of 40 score: 31.570218677487215
Financial ratios for LOGN.SW — quarterly report dated 2025-09-30
Total revenue: 1482570000
Gross profit: 643070000
Operating income: 244666250
Net income: 213337500
Capital expenditures: 20696250
Operating cash flow: 286046250
Depreciation & amortization: 24838750
Net tangible assets: 2001193750
Owner earnings: 217480000
Return on net tangible assets (%): 10.867513452907795
Capex to operating income (%): 8.458972171274134
Buffett classification: The Great
Stock price: 108.475
P/E ratio: 27.831040785261347
Shares outstanding: 143566251
Book value: 2603766250
P/B ratio: 5.98108569739123
Market cap (USD): 15573349077.224998
Debt to equity: 0.04572895128354936
Current ratio: 2.1459578589361485
Quick ratio: 1.7419560265123935
Effective tax rate (%): 15.948880845091232
COGS to revenue (%): 56.624645042055356
R&D to revenue (%): 6.417066310528339
SG&A to revenue (%): 20.302161112122867
Free cash flow (dilution-adjusted): 227460000
Buyback yield (%): 0.8556765750205931
Retained earnings: 3733470000
Inventory turnover: 1.2973440762798136
Receivables turnover: 1.572163677575854
Capitalized R&D asset: 187425237.5
ROCI (R&D-adjusted, %): 7.668010713151381
Rosenberg metric: 0.47587381179025834
FCF margin (%): 15.342277261781906
Revenue growth (%): 3.3417181971293966
Rule of 40 score: 18.6839954589113
Financial ratios for LOGN.SW — quarterly report dated 2025-12-31
Total revenue: 1799340506.329114
Gross profit: 778024050.6329113
Operating income: 362627848.1012658
Net income: 317770886.0759494
Capital expenditures: 18848101.265822783
Operating cash flow: 608268354.4303797
Depreciation & amortization: 24272151.898734175
Net tangible assets: 2348424050.632911
Owner earnings: 323194936.70886075
Return on net tangible assets (%): 13.762205195512209
Capex to operating income (%): 5.197643083539284
Buffett classification: The Great
Stock price: 103.21518987341773
P/E ratio: 16.88996648527196
Shares outstanding: 143566251
Book value: 2956611392.405063
P/B ratio: 5.011892294822632
Market cap (USD): 14818217856.379747
Debt to equity: 0.03938052585858854
Current ratio: 2.2135755088419384
Quick ratio: 1.8943753128672307
Effective tax rate (%): 16.076956507204226
COGS to revenue (%): 56.76059934758093
R&D to revenue (%): 5.519040379773461
SG&A to revenue (%): 17.5026152338515
Free cash flow (dilution-adjusted): 559755696.2025317
Buyback yield (%): 0.23164267652414075
Retained earnings: 4098500000
Inventory turnover: 1.794796504902746
Receivables turnover: 1.9243554024893121
Capitalized R&D asset: 193815591.61392406
ROCI (R&D-adjusted, %): 10.180501590106234
Rosenberg metric: 1.4185158390005133
FCF margin (%): 31.108936537226374
Revenue growth (%): 21.36631028073642
Rule of 40 score: 52.4752468179628
Financial ratios for LSL.V — annual report dated 2023-12-31
Total revenue: 7596969.696969696
Gross profit: 1246212.121212121
Operating income: -3118181.818181818
Net income: -6418181.818181817
Capital expenditures: 496969.69696969696
Operating cash flow: -5356060.6060606055
Depreciation & amortization: 855303.0303030303
Net tangible assets: -209090.9090909091
Owner earnings: -6059848.484848484
Buffett classification: The Gruesome
Stock price: 0.3712121212121212
Shares outstanding: 126729818
Book value: 6556818.18181818
P/B ratio: 7.1747672813402685
Market cap (USD): 47043644.56060606
Debt to equity: 1.8797227036395152
Current ratio: 0.4779089823537216
Quick ratio: 0.2053204192649595
Interest coverage ratio: -2.6216560509554134
COGS to revenue (%): 83.59593139210212
R&D to revenue (%): 0.6980454726765057
SG&A to revenue (%): 56.09293976864779
Free cash flow (dilution-adjusted): -7730303.03030303
Buyback yield (%): 0
Retained earnings: -13813636.363636363
Inventory turnover: 2.040155755658311
Receivables turnover: 3.739000745712155
Capitalized R&D asset: 382611.1853832442
ROCI (R&D-adjusted, %): -26.243109652139356
Rosenberg metric: 5.780042578248857
FCF margin (%): -101.75508575987237
Revenue growth (%): 25.78376902701227
Rule of 40 score: -75.9713167328601
Financial ratios for LSL.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3259259259259259
Shares outstanding: 126729818
Market cap (USD): 41304533.27407407
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0